Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
About
About the Journal
Privacy Statement
Open access policy
Contact
Current
Archives
Editorial Board
Procedure for consideration and publication of materials
Guides for authors
Cost of publication
Archive 2018-2006
Search
Login
Home
/
Archives
/
Vol. 43 No. 3 (2021): Experimental Oncology
Vol. 43 No. 3 (2021): Experimental Oncology
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3
Published:
26.05.2023
Original contributions
11q23/MLL rearrangements in adult acute leukemia
O.V. Zotova, A.S. Lukianova, M.O. Valchuk, Yu.S. Karol, O.O. Shalay, V.L. Novak, V.E. Loginsky
229-233
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16495
Redox dependent features of tumors, adipose tissue, neutrophiles and platelets in patients with metastatic colorectal cancer
A.P. Burlaka, S.V. Virko, A.A. Burlaka, K.L. Krupnyk
261-265
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16571
Expression pattern of MRPS18 family genes in gliomas
L.M. Kovalevska, T.A. Malysheva, S.S. Kalman, A.V. Rozumenko, L.V. Verbova, V.D. Rozumenko, E.V. Kashuba
204-208
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16461
Neutrophil to lymphocyte ratio as a prognostic marker for non-metastatic renal cell carcinoma — does it add to what we already know?
S. Rawoot, C. Punatar, V. Singh, A. Anand, B. Shah, S. Nagaonkar, V. Joshi
247-251
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16543
Safety profile and clinical outcome of adjuvant radiation therapy and intermediate-dose interferon in comparison with intermediate-dose interferon alone in patients with melanoma metastases in regional lymph nodes and unfavorable prognostic factors
M. Kukushkina, S. Korovin, S. Diedkov, V. Ostafiichuk, A. Diedkov
257-260
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16524
A nutrient mixture reduced tumor growth of SK-UT-1 human leiomyosarcoma cells in vivo and in vitro by inhibiting MMPs and inducing apoptosis
M.W. Roomi, B. Bhanap, A. Niedzwiecki, M. Rath
209-216
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16604
Magnetically sensitive nanocomplex enhances antitumor efficacy of dendritic cell-based immunotherapy
N. Khranovska, O. Skachkova, O. Gorbach, M. Inomistova, V. Orel
217-223
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16507
Experimental substantiation of the use of hydroxyapatite — tricalcium phosphate bioceramics for replacing bone defects after tumor removal
V.F. Konovalenko, N.K. Ternovyi, E.V. Tuz, V.V. Protsenko, E.O. Solonitsyn, A. Audai, O.V. Drobotun, N.V. Ulianchych
237-241
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16584
Association of lipoprotein lipase expression with TP53 gene polymorphisms in chronic lymphocytic leukemia cells
I. Abramenko, N. Bilous, A. Chumak, I. Dyagil, Z. Martina
224-228
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16474
Evaluation of serum levels of selected cytokine receptors in adult B-cell precursor acute lymphoblastic leukemia and their association with prognostic factors and survival
J.M. Horacek, T. Kupsa, J. Vanek, M. Jakl, M. Stajer, L. Jebavy, P. Zak
234-236
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16548
Oxamate, an inhibitor of lactate dehydrogenase, can stimulate M2 polarization of peritoneal macrophages in mice with Lewis lung carcinoma
G.I. Solyanik, O.M. Karaman, Y.R. Yakshibaeva, O.N. Pyaskovskaya, D.L. Kolesnyk
270-273
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16530
Influence of bacterial lectin on key regulatory links of functional activity of macrophages in mice with Ehrlich carcinoma
A.V. Chumak, N.I. Fedosova, V.M. Shcherbina, N.L. Cheremshenko, O.M. Karaman, V.F. Chekhun
197-203
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16537
Effects of brachytherapy on cytogenetic parameters and oxidative status in peripheral blood lymphocytes of gynecologic cancer patients
V.S. Ivankova, E.A. Domina, T.V. Khrulenko, L.I. Makovetska, O.O. Hrinchenko, L.M. Baranovska
242-246
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16514
Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis
M.S. Vlachou, D. Mauri, G. Zarkavelis, P. Ntellas, C. Tagkas, S. Gkoura, G. Pentheroudakis
252-256
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16592
Short communications
ESR1 gene variants affect FSHR-depended risk of fibrocystic mastopathy in infertile women
A.G. Kornatska, Z.I. Rossokha, L.Ye. Fishchuk, O.D. Dubenko, N.L. Medvedieva, М.А. Flaksemberg, G.V. Chubei, O.F. Popova, N.G. Gorovenko
266-269
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16468
Point of view
Can SARS-CoV-2 change individual radiation sensitivity of the patients recovered from COVID-19? (experimental and theoretical background)
V.F. Chekhun, E.A. Domina
277-280
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16554
Case report
Collision breast cancer and chronic lymphocytic leukemia/small lymphocytic lymphoma in a single lymph node (clinical case)
L. Zakhartseva, M. Yanovytska
274-276
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-3.16486
Editorial
TO THE THIRTIES ANNIVERSARY OF THE INDEPENDENCE OF UKRAINEPRIORITIES IN CANCER RESEARCH: RETROSPECTIVE AND PROSPECTIVE ASPECTS
194-196
PDF
Language
Українська
English
Current Issue